Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer

Abstract We have previously shown that aberrant promoter methylation of ZNF331 is a potential biomarker for colorectal cancer detection with high sensitivity (71%) and specificity (98%). This finding was recently confirmed by others, and it was additionally suggested that promoter methylation of ZNF...

Full description

Bibliographic Details
Main Authors: Hege Marie Vedeld, Arild Nesbakken, Ragnhild A. Lothe, Guro E. Lind
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Clinical Epigenetics
Subjects:
Colorectal cancer
Diagnosis
DNA methylation
Prognosis
ZNF331
Online Access:http://link.springer.com/article/10.1186/s13148-018-0503-2

Similar Items

Similar Items